Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
954
archived clinical trials in
Fibromyalgia

Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
970
mi
from 43215
Fort Lauderdale, FL
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
970
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
922
mi
from 43215
Fort Myers, FL
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
922
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
411
mi
from 43215
Athens, GA
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
411
mi
from 43215
Athens, GA
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
430
mi
from 43215
Decatur, GA
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
430
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
348
mi
from 43215
Peoria, IL
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
348
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
280
mi
from 43215
Evansville, IN
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
280
mi
from 43215
Evansville, IN
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
302
mi
from 43215
Madisonville, KY
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
302
mi
from 43215
Madisonville, KY
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
331
mi
from 43215
Columbia, MD
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
331
mi
from 43215
Columbia, MD
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
300
mi
from 43215
Frederick, MD
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
300
mi
from 43215
Frederick, MD
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
642
mi
from 43215
Brockton, MA
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
642
mi
from 43215
Brockton, MA
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
113
mi
from 43215
Mogadore, OH
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
113
mi
from 43215
Mogadore, OH
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
121
mi
from 43215
Toledo, OH
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
121
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Goose Creek, SC
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
mi
from 43215
Goose Creek, SC
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
508
mi
from 43215
Memphis, TN
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2000
mi
from 43215
Kirkland, WA
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2000
mi
from 43215
Kirkland, WA
Click here to add this to my saved trials
Propranolol for Treating Fibromyalgia Pain
Propranolol for Treating Fibromyalgia Pain: Pilot Study
Status: Enrolling
Updated:  12/31/1969
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Propranolol for Treating Fibromyalgia Pain
Propranolol for Treating Fibromyalgia Pain: Pilot Study
Status: Enrolling
Updated: 12/31/1969
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated:  12/31/1969
Pfizer Investigational Site
689
mi
from 43215
Destin, FL
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
689
mi
from 43215
Destin, FL
Click here to add this to my saved trials
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated:  12/31/1969
Pfizer Investigational Site
689
mi
from 43215
Fort Walton Beach, FL
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
689
mi
from 43215
Fort Walton Beach, FL
Click here to add this to my saved trials
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated:  12/31/1969
Pfizer Investigational Site
165
mi
from 43215
Ann Arbor, MI
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
165
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated:  12/31/1969
Pfizer Investigational Site
176
mi
from 43215
Bingham Farms, MI
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
176
mi
from 43215
Bingham Farms, MI
Click here to add this to my saved trials
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated:  12/31/1969
Pfizer Investigational Site
851
mi
from 43215
Oklahoma City, OK
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
851
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated:  12/31/1969
Pfizer Investigational Site
1058
mi
from 43215
Austin, TX
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
1058
mi
from 43215
Austin, TX
Click here to add this to my saved trials
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated:  12/31/1969
Pfizer Investigational Site
910
mi
from 43215
Dallas, TX
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
006 Research Facility
mi
from 43215
DeLand, FL
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
006 Research Facility
mi
from 43215
DeLand, FL
Click here to add this to my saved trials
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
005 Research Facility
mi
from 43215
Charlotte, NC
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
005 Research Facility
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
004 Research Facility
mi
from 43215
Medford, OR
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
004 Research Facility
mi
from 43215
Medford, OR
Click here to add this to my saved trials
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
002 Research Facility
mi
from 43215
Portland, OR
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
002 Research Facility
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
001 Research Facility
mi
from 43215
San Antonio, TX
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
001 Research Facility
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
003 Research Facility
mi
from 43215
San Antonio, TX
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
003 Research Facility
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Lifestyle Physical Activity to Reduce Pain and Fatigue in Adults With Fibromyalgia
Lifestyle Physical Activity for Fibromyalgia
Status: Enrolling
Updated:  3/31/2009
Johns Hopkins Bayview Medical Center
347
mi
from 43215
Baltimore, MD
Lifestyle Physical Activity to Reduce Pain and Fatigue in Adults With Fibromyalgia
Lifestyle Physical Activity for Fibromyalgia
Status: Enrolling
Updated: 3/31/2009
Johns Hopkins Bayview Medical Center
347
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Coping Skills Training for Adolescents With Fibromyalgia
Randomized Clinical Trial in Juvenile Fibromyalgia
Status: Enrolling
Updated:  4/24/2009
Kosair Charities Pediatric Center
188
mi
from 43215
Louisville, KY
Coping Skills Training for Adolescents With Fibromyalgia
Randomized Clinical Trial in Juvenile Fibromyalgia
Status: Enrolling
Updated: 4/24/2009
Kosair Charities Pediatric Center
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Coping Skills Training for Adolescents With Fibromyalgia
Randomized Clinical Trial in Juvenile Fibromyalgia
Status: Enrolling
Updated:  4/24/2009
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Coping Skills Training for Adolescents With Fibromyalgia
Randomized Clinical Trial in Juvenile Fibromyalgia
Status: Enrolling
Updated: 4/24/2009
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Coping Skills Training for Adolescents With Fibromyalgia
Randomized Clinical Trial in Juvenile Fibromyalgia
Status: Enrolling
Updated:  4/24/2009
Cleveland Clinic Foundation, Division of Pediatrics
138
mi
from 43215
Cleveland, OH
Coping Skills Training for Adolescents With Fibromyalgia
Randomized Clinical Trial in Juvenile Fibromyalgia
Status: Enrolling
Updated: 4/24/2009
Cleveland Clinic Foundation, Division of Pediatrics
138
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain
Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Widespread Pain (CWP)
Status: Enrolling
Updated:  9/29/2009
Harborview Medical Center
2006
mi
from 43215
Seattle, WA
Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain
Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Widespread Pain (CWP)
Status: Enrolling
Updated: 9/29/2009
Harborview Medical Center
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Study to Assess Mechanisms in Peripheral Tissue Innervation for Fibromyalgia
Duloxetine(Cymbalta) for Fibromyalgia: An Open-Label Pilot Study to Assess Potential Mechanisms for Fibromyalgia in Peripheral Tissue Innervation That Could Predict Therapeutic Responsiveness to Duloxetine
Status: Enrolling
Updated:  6/21/2011
Neurosciences Institute, Albany Medical College
513
mi
from 43215
Albany, NY
Study to Assess Mechanisms in Peripheral Tissue Innervation for Fibromyalgia
Duloxetine(Cymbalta) for Fibromyalgia: An Open-Label Pilot Study to Assess Potential Mechanisms for Fibromyalgia in Peripheral Tissue Innervation That Could Predict Therapeutic Responsiveness to Duloxetine
Status: Enrolling
Updated: 6/21/2011
Neurosciences Institute, Albany Medical College
513
mi
from 43215
Albany, NY
Click here to add this to my saved trials
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Status: Enrolling
Updated:  6/23/2011
ETSU College of Medicine Department of Psychiatry
255
mi
from 43215
Johnson City, TN
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Status: Enrolling
Updated: 6/23/2011
ETSU College of Medicine Department of Psychiatry
255
mi
from 43215
Johnson City, TN
Click here to add this to my saved trials
Fibromyalgia of Less Than One Year Duration. Study of Pregabalin
Fibromyalgia of Less Than One Year Duration in Primary Care: Treatment Response in a Double Blind, Placebo Controlled Study of Pregabalin
Status: Enrolling
Updated:  7/21/2011
Newton-Wellesley Hospital
635
mi
from 43215
Newton, MA
Fibromyalgia of Less Than One Year Duration. Study of Pregabalin
Fibromyalgia of Less Than One Year Duration in Primary Care: Treatment Response in a Double Blind, Placebo Controlled Study of Pregabalin
Status: Enrolling
Updated: 7/21/2011
Newton-Wellesley Hospital
635
mi
from 43215
Newton, MA
Click here to add this to my saved trials
Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study
Novel Use of Ketotifen (Mast Cell Stabilizer) in Fibromyalgia: A Pilot Study
Status: Enrolling
Updated:  3/12/2012
IU Clincial Research Center for Pain and Fibromyalgia
166
mi
from 43215
Indianapolis, IN
Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study
Novel Use of Ketotifen (Mast Cell Stabilizer) in Fibromyalgia: A Pilot Study
Status: Enrolling
Updated: 3/12/2012
IU Clincial Research Center for Pain and Fibromyalgia
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Qigong Exercise May Benefit Patients With Fibromyalgia
Qigong Exercise May Benefit Patients With Fibromyalgia
Status: Enrolling
Updated:  6/4/2012
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
Qigong Exercise May Benefit Patients With Fibromyalgia
Qigong Exercise May Benefit Patients With Fibromyalgia
Status: Enrolling
Updated: 6/4/2012
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
Click here to add this to my saved trials
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated:  6/28/2012
Superior Research LLC
2043
mi
from 43215
Sacramento, CA
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
Superior Research LLC
2043
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated:  6/28/2012
Avail Clinical Research
760
mi
from 43215
DeLand, FL
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
Avail Clinical Research
760
mi
from 43215
DeLand, FL
Click here to add this to my saved trials
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated:  6/28/2012
Renstar Medical Research
746
mi
from 43215
Ocala, FL
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
Renstar Medical Research
746
mi
from 43215
Ocala, FL
Click here to add this to my saved trials
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated:  6/28/2012
University of Kentucky
154
mi
from 43215
Lexington, KY
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
University of Kentucky
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated:  6/28/2012
Columbia Medical Practice
331
mi
from 43215
Columbia, MD
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
Columbia Medical Practice
331
mi
from 43215
Columbia, MD
Click here to add this to my saved trials
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated:  6/28/2012
The Center for Rheumatology and Bone Research
324
mi
from 43215
Wheaton, MD
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
The Center for Rheumatology and Bone Research
324
mi
from 43215
Wheaton, MD
Click here to add this to my saved trials